Supplementing the standard of treatment for early-stage Alzheimer’s disease patients with personalized lifestyle coaching leads to less cognitive decline compared to standard of care alone, an ISB-led study shows. An early online version of this paper detailing the findings has been published, and it is scheduled for publication in the November issue of Journal of Alzheimer’s Disease.